CUMBERLAND PHARMACEUTICALS INC
Ticker: 1087294
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 8.80-3.6% | 9.13+10.1% | 8.29-23.5% | 10.84-7.4% | 11.71+28.8% | 9.09-7.7% | 9.85+15.9% | 8.50 |
| Total Income | 8.80-3.6% | 9.13+10.1% | 8.29-23.5% | 10.84-7.4% | 11.71+28.8% | 9.09-7.7% | 9.85+15.9% | 8.50 |
| EXPENSES | ||||||||
| Expenditure | 3.33-72.8% | 12.26+19.5% | 10.26-11.4% | 11.58+11.1% | 10.42-3.3% | 10.78-0.9% | 10.88+4.9% | 10.37 |
| Tax | 0.00 | 0.00-100.0% | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01 |
| PROFIT | ||||||||
| PBT | -3.10+1.3% | -3.14-61.9% | -1.94-165.8% | -0.73-158.4% | 1.25+181.7% | -1.53-40.4% | -1.09+42.3% | -1.89 |
| Net Profit | -4.28-30.1% | -3.29-69.6% | -1.94-162.2% | -0.74-158.7% | 1.26+181.8% | -1.54-41.3% | -1.09+44.1% | -1.95 |
| KEY METRICS | ||||||||
| OPM % | -35.91%-1.64pp | -34.27%-10.57pp | -23.70%-16.80pp | -6.90%-17.93pp | 11.03%+29.68pp | -18.65%-8.23pp | -10.42%+11.57pp | -22.00% |
| NPM % | -48.59%-12.56pp | -36.03%-12.62pp | -23.40%-16.57pp | -6.83%-17.57pp | 10.73%+27.73pp | -16.99%-5.97pp | -11.02%+11.88pp | -22.90% |
| EPS | -0.29-31.8% | -0.22-69.2% | -0.13-160.0% | -0.05-162.5% | 0.08+172.7% | -0.11-37.5% | -0.08+42.9% | -0.14 |
Corporate Events
Board MeetingCPIX
202624Jun
Board Meeting
Shareholders approved the proposal to authorize and approve …
SEC Filing ↗ Board MeetingCPIX
202621Apr
Board Meeting
Shareholders voted on the frequency of future advisory votes…
SEC Filing ↗